Meldungen - #ImpfwissenSchützt – Falschinformationen mit Fakten begegnen
Covid19-Sources
COVID-19-related premature ovarian insufficiency: case report and literature review
Yunlong Richard Cao on Twitter
Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein
Study helps explain SARS-CoV-2 variants' rapid spread
Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study
Neutralization, effector function and immune imprinting of Omicron variants
COVID infection risk rises the longer you are exposed — even for vaccinated people
Health misinformation in the US: education plays a particularly important role
A GP with long COVID on the webinar ‘Long COVID: what needs to happen next?’
Dashboard SentiSurv RLP
A Quick Update on the BA.2.86 Variant
Is It Time to Worry About the New COVID Variant?
Florian Krammer on Twitter
Dr. Christian Kroener 📯 on Twitter
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
Das offizielle Dashboard zum aktuellen COVID-19 Pandemiegeschehen in der Bundesrepublik Deutschland
Excess All-Cause Mortality in China After Ending the Zero COVID Policy
IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding | Proceedings of the National Academy of Sciences
Neue PASC-Falldefinition: Jeder zehnte Patient leidet nach Omikron-Infektion unter Long COVID
Postacute sequelae of COVID-19 at 2 years
Fig. 1: Risk of postacute sequelae of COVID-19 up to 2 years after infection by care setting of the acute phase of the disease.Relative risks by days after infection plotted for time periods of 30–90, 91–180, 181–360, 361–540 and 541–720 days after infection, labeled by the last day of the corresponding time period. Heatmaps include (top row) nonhospitalized for COVID-19 during the acute phase of the disease (n = 118,238) corresponding to each sequela and (bottom row) COVID-19 hospitalization during the acute phase of the disease (n = 20,580). Relative risks were estimated in comparison to a noninfected control (n = 5,985,227). Sequelae are grouped by organ system. ACD, acute coronary disease; AIM, abnormal involuntary movements; AKI, acute kidney injury; CKD, chronic kidney disease; DVT, deep vein thrombosis; ESKD, end-stage kidney disease; GAD, general anxiety disorder; GERD, gastroesophageal reflux disease; IBS, irritable bowel syndrome; ICM, ischemic cardiomyopathy; ILD, interstitial lung disease; MI, myocardial infarction; NCD, neurocognitive decline; NICM, nonischemic cardiomyopathy; PTSD, post-traumatic stress disorder; PUD, peptic ulcer disease; TIA, transient ischemic attack; VTE, venous thromboembolism. NS, non-significant.
Postacute sequelae of COVID-19 at 2 years
Early Omicron infection is associated with increased reinfection risk in older adults in long-term care and retirement facilities
Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort
Seroepidemiology of the Seasonal Human Coronaviruses NL63, 229E, OC43 and HKU1 in France
Prof. Dr. Sanjeev Bagai on Twitter
Incidence of New-Onset Hypertension Post–COVID-19: Comparison With Influenza
Late Mortality After COVID-19 Infection in Veterans vs Risk-Matched Comparators
Eric Topol on Twitter